Foodgeist is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com. As an Amazon Associate we earn from qualifying purchases.
Ingredient
Derived from flavor compounds · verified measured labels + GNN ensemble predictions
1 compound identified — FoodAtlas / FooDB verified
Highlighted compounds are flavor-active · click to view molecular profile
“seed oil from bitter melon (Momordica charantia) (BMO), which is rich in cis(c)9, trans(t)11, t13-conjugated linolenic acid (CLN), inhibited the development of azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF)”
bitter melon seed oil (BMO) → inhibits → azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF)
“Such inhibition was associated with the increased content of CLA (c9,t11-18:2) in the lipid composition in colonic mucosa and liver”
bitter melon seed oil (BMO) → increases content → CLA (c9,t11-18:2) in colonic mucosa and liver
“Dietary supplementation with 0.01% and 0.1% BMO caused significant reduction in the incidence (47% inhibition by 0.01% BMO, p<0.02; 40% inhibition by 0.1% BMO, p<0.05; and 17% inhibition by 1% BMO)”
bitter melon seed oil (BMO) → reduces incidence → colonic adenocarcinoma
“Dietary supplementation with 0.01% and 0.1% BMO caused significant reduction in the incidence (47% inhibition by 0.01% BMO, p<0.02; 40% inhibition by 0.1% BMO, p<0.05; and 17% inhibition by 1% BMO)”
bitter melon seed oil (BMO) → reduces incidence → colonic adenocarcinoma
“Dietary supplementation with 0.01% and 0.1% BMO caused significant reduction in the multiplicity (64% inhibition by 0.01% BMO, p<0.005; 58% inhibition by 0.1% BMO, p<0.02; and 48% inhibition by 1% BMO, p<0.05)”
bitter melon seed oil (BMO) → reduces multiplicity → colonic adenocarcinoma